Navigation Links


Nuvion in Medical Technology

PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week

Nuvion Antibody Led to a Sustained Response and Remission in Follow-up to Phase 1 and Phase 1/2 studies and Was Adequately Tolerated in Patients with IV Steroid-Refractory Ulcerative Colitis FREMONT, Calif., May 22, 2007 /PRNewswire-FirstCall/ -- Data presented at the Digestive Disease Week (DDW) ...
Nuvion in Biological Technology

PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development

...al trial, the company has decided to terminate the nuvion (visilizumab) phase 3 program in ulcerative coliti...icient resources to advance these opportunities." nuvion (visilizumab) Pivotal Program Termination Following review of data communicated by the nuvion DMC this past Friday, August 24, PDL has decided t...
Nuvion in other areas

Nuvion - MyMiniCity

To improve Nuvion, you only have to give the following links to your friends or ... 19 August: The police force of Nuvion has been reinforced. ...

Nuvion

A new inhabitant has come to Nuvion. A new factory has just opened. A new inhabitant has come to Nuvion. The transport network of Nuvion has been improved. ...

PDL BioPharma Advances Nuvion(R) Into Second Pivotal Study In ...

PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will advance its Nuvion(R) (visilizumab) antibody in patients with intravenous steroid ...

Hutch researchers present preliminary results with antibody to treat ...

Early testing of Nuvion has indicated that the antibody is well tolerated and ... These results predict that Nuvion might be able to induce a state of ...

CCFA.org: Nuvion(R) Into Second Study In Intravenous Steroid-Refractory ...

PDL BioPharma Advances Nuvion® Into Second Pivotal Study In Intravenous Steroid ... ongoing phase 2/3 clinical trial of the Nuvion antibody in patients with IVSR-UC. ...

PDL BioPharma Shares May Fall on Sell-off of Products, Job Cuts ...

PDL BioPharma Inc., the developer of technology for cancer medicines, may fall in Nasdaq trading after it announced plans ... negative that Nuvion is lost, ...
Other TagsRemove
(Date:11/27/2009)..., , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewsw...sdaq: SHMR ) ( "Shamir" ), a leading provider of ...ic lens market, announced today that its board of ...an aggregate amount of US$ 10 million (approximate...9 representative rate of exchange), or approximate...
(Date:11/27/2009)...oaring rates to bring unprecedented medical, econo...Nov. 27 (HealthDay News) -- The number of people w...ouble over the next 25 years, a new study predicts... 44.1 million people with the disease, up from 23....of treating people with diabetes will triple, the ...
(Date:11/27/2009)... Multi-purpose bilingual c...Designed for use by the business community to educ...ty of subjects from Safety issues to Dinosuars to ... Saint Louis, MO (PRWEB) November 27, 20...electronics or toys to keep them busy any hour of ...
(Date:11/26/2009)..., , NEW YORK, Nov. 27 With ...han ever to employ good practices to control the s...eed to be proactive not only to keep ourselves hea...ick," said Eileen Finerty, RN, MS, CIC (certified ...ion control and occupational health at Hospital fo...
(Date:11/26/2009)... The copper sequestering drug tetrathiomolybdate (...he treatment of Wilson disease, a disease caused b...ncers. That much is known. Very little, however, i...level. , A new study led by Northwestern Univers...e: the three-dimensional structure of TM bound to ...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
(Date:11/23/2009).... November 23, 2009 Applied mathematicians disse...ancifolia ), a characteristic long leaf with a sad... along the edges. The simple cause of the lily,s f...ding during differential growthwas revealed by usi...bbons. , Haiyi Liang, a postdoctoral student at ...
(Date:11/23/2009)...e Wildlife Conservation Society says that western ...public of Congopart of the "mother lode" of more t...ing increasingly threatened by growing humans acti...ction of the swamp forests adjacent to the southwe... surveys confirmed that high densities of the grea...
(Date:11/23/2009)...rent research suggests that a common oral bacteriu...report by Nichols et al, "Unique Lipids from a Com...Ligands Capable of Enhancing Autoimmunity," appear...nal of Pathology . , Multiple sclerosis (MS), a ...and spinal cord, affects nearly 1 in 700 people in...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 1Arcadia Resources Announces Closing of 2411 1 Million Financing 61915 2Inimex Announces Appointment of New CEO 14941 1Inimex Announces Appointment of New CEO 14941 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 14939 1Pearl Therapeutics Appoints Howie Rosen to Board of Directors 14939 2
Other Contentsovulesovumovumovumovumoxidationoxidationoxidationoxidationoxidationoxidationoxygenoxygenoxygenoxygenoxygenoxygenoxygenoxygenoxygenoxygenatedoxygenatedoxygenatedelementselementselementselementselementselementselementselementselementspachytene